FCPM III SERVICES B.V. logo

FCPM III SERVICES B.V. Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for FCPM III SERVICES B.V. with $500.4M in long positions as of Q3 2025, 95% allocated to Healthcare, and 100% concentrated in top 10 positions.

Portfolio Value
$500.4M
Top 10 Concentration
100%
Top Sector
Healthcare (95%)
US Exposure
34%
Market Cap Focus
Mid Cap
Countries
3

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 94.70%Healthcare
Healthcare
94.70%

Industry Breakdown

1 industry across all sectors

Biotechnology: 94.66%Biotechnology
Biotechnology
Healthcare
94.66%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 52.36%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 41.89%Small Cap ($300M - $2B)N/A (ETF or Unknown): 5.75%
Mid Cap ($2B - $10B)
52.36%
Small Cap ($300M - $2B)
41.89%
N/A (ETF or Unknown)
5.75%

Portfolio Concentration

Top 10 Holdings %
100.0%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
34.08%
International
65.92%
Countries
3
Largest Int'l Market
Netherlands - 52.36%
Netherlands
52.36% ($262.0M)
1 holdings
United States of America
34.08% ($170.5M)
6 holdings
Canada
13.56% ($67.9M)
2 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
4.9 quarters
Avg. Top 20
4.9 quarters
Avg. All Positions
4.9 quarters
Median Holding Period
7 quarters
Persistence Rate
66.67%
Persistent Holdings Weight
88.55%
Persistent Positions
6
Longest Held
enGene Holdings Inc. Common Stock logo
enGene Holdings Inc. Common StockENGN - 7 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
3.70%
Avg. Position Weight
11.11%
Largest Position
NewAmsterdam Pharma Company N.V. Ordinary Shares logo
NewAmsterdam Pharma Company N.V. Ordinary SharesNAMS - 52.36%
Largest Ownership Stake
enGene Holdings Inc. Common Stock logo
enGene Holdings Inc. Common StockENGN - 18.82%
Avg. Ownership Stake
8.15%
Ownership Stake >5%
5
Ownership Stake >1%
7

Historical (Since Q4 2023)

Avg. New Position
11.53%
Avg. Ownership Stake
10.38%
Largest Position
NewAmsterdam Pharma Company N.V. Ordinary Shares logo
NewAmsterdam Pharma Company N.V. Ordinary SharesNAMS - 54.11% (Q1 2025)
Largest Ownership Stake
enGene Holdings Inc. Common Stock logo
enGene Holdings Inc. Common StockENGN - 37.41% (Q4 2023)

Portfolio Turnover

Current Quarter

Turnover Ratio
6.2%
Value Traded
$31.19M
Positions Added
1
Positions Exited
0

Historical (Since Q4 2023)

Avg. Turnover Ratio
10.2%
Avg. Positions Added
1
Avg. Positions Exited
0
Highest Turnover
50.0%
Q4 2023
Lowest Turnover
1.4%
Q2 2025

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.